Regulation of muscle creatine kinase by phosphorylation in normal and diabetic hearts

G Lin1, Y Liu, K M MacLeod

  • 1Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC V6T 1Z3, Canada.

Insights

Protein kinase C (PKC) phosphorylates muscle creatine kinase (M-CK) at serine 128. This modification impacts M-CK

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Protein kinase C (PKC) is a key signaling pathway in cardiac function.
  • The specific targets and roles of PKC in the heart are not fully understood.
  • Muscle creatine kinase (M-CK) plays a vital role in cardiac energy metabolism.

Purpose of the Study:

  • To identify cardiac targets of Protein Kinase C (PKC).
  • To investigate the role of M-CK phosphorylation in cardiac function, particularly in diabetes.

Main Methods:

  • Utilized a PKC substrate antibody to detect phosphorylated proteins.
  • Identified M-CK via tandem mass spectrometry.
  • Assessed M-CK enzymatic activity following dephosphorylation by protein phosphatases (PP2A, PP2C).
  • Compared M-CK phosphorylation and activity in diabetic versus control hearts.

Main Results:

  • Identified a 40-kDa cardiac protein as M-CK, phosphorylated at serine 128 by PKC.
  • Dephosphorylation of M-CK by PP2A or PP2C altered its forward and reverse reaction kinetics.
  • Diabetic hearts showed reduced M-CK phosphorylation despite increased PKC levels.
  • Observed decreased M-CK phosphorylation in diabetic hearts mirrored activity changes seen after M-CK dephosphorylation in control hearts.

Conclusions:

  • PKC directly phosphorylates M-CK at serine 128, influencing its enzymatic activity.
  • Reduced M-CK phosphorylation in diabetic hearts may be a compensatory mechanism to maintain ATP regeneration.
  • This study elucidates a novel regulatory pathway for cardiac energy metabolism involving PKC and M-CK.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.